Geneva Court Grants Temporary Moratorium to ObsEva
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange Geneva, Switzerland – 31 January 2024 – ObsEva SA (SIX: OBSN), […]
Vaxcyte Announces Pricing of $750 Million Public Offering
SAN CARLOS, Calif., Jan. 30, 2024 (GLOBE NEWSWIRE) — Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity […]
Immunocore Prices Upsized Convertible Senior Notes Offering
Immunocore Prices Upsized Convertible Senior Notes Offering (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md, January 30, 2024) Immunocore Holdings […]
TSX News -
BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting
PHILADELPHIA and VANCOUVER, British Columbia, Jan. 30, 2024 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX:BCT) (“BriaCell” or […]
23andMe Launches Month-Long Initiative to Amplify ARRAY’s “Seat16” Program for Acclaimed Film ORIGIN by Ava DuVernay
SUNNYVALE, Calif., Jan. 30, 2024 (GLOBE NEWSWIRE) — 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading genetic health and biopharmaceutical […]
Check Point Software Unveils Infinity AI Copilot: Transforming Cyber security with Intelligent GenAI Automation and Support
BANGKOK, Thailand, Jan. 30, 2024 (GLOBE NEWSWIRE) — Check Point Software Technologies Ltd. (NASDAQ: CHKP), a leading AI-powered, cloud-delivered cyber […]
Appendix 4C Quarterly Activity Report for Quarter Ended December 31, 2023
NEW YORK, Jan. 30, 2024 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for […]
Regenx Revises Non-Brokered Financing for Gross Proceeds to $1.7 Million
EDMONTON, Alberta, Jan. 30, 2024 (GLOBE NEWSWIRE) — Regenx Tech Corp. (the “Company” or “Regenx”) (CSE: RGX) (OTCQB: RGXTF) (FSE: […]
Osino Announces Receipt of Interim Order and Closing of Second and Final Tranche of Bridge Private Placement
VANCOUVER, British Columbia, Jan. 30, 2024 (GLOBE NEWSWIRE) — Osino Resources Corp. (TSXV:OSI) (NSX:OSN) (FSE:RSR1) (OTCQX:OSIIF) (“Osino” or the “Company“) […]
Corbus Pharmaceuticals Announces Proposed Public Offering
NORWOOD, Mass., Jan. 30, 2024 (GLOBE NEWSWIRE) — Corbus Pharmaceuticals Holdings, Inc. (Nasdaq: CRBP) (“Corbus” or the “Company”), a precision […]
